Tissue inhibitor of metalloproteinases-2 (TIMP-2) and Insulin-like growth factor binding protein-7 (IGFBP7), as highlighted by Engelman et al. (2019), have been associated with reducing AKI incidence following cardiac surgery, demonstrating the clinical utility of biomarker-guided interventions [30]. Here, TIMP2 is linked to acute kidney injury.